Overview / Abstract: |
The increasing understanding of the immunopathogenesis of MS and the greater availability of disease-modifying therapies (DMTs) have shifted the aims of treatment. Modification of therapies is increasingly common in the context of growing knowledge of MS pathophysiology and DMT mechanisms of action. Education is needed to reformulate treatment strategies on the individual and systems levels. Goals (Purpose) of Program |
Expiration |
Sep 12, 2018 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
0.5 contact hours |
Accreditation |
ACCME, ANCC |
Presenters / Authors / Faculty |
Edward Fox, MD, PhD Director, Multiple Sclerosis Clinic Lori Mayer, DNP, MSN, RN, MSCN |
Sponsors / Supporters / Grant Providers |
Genentech, Inc. |
Keywords / Search Terms |
CMEology Neurology, disease-modifying therapies, DMTs, MS, Multiple Sclerosis, physicians, CME, Continuing Education, Continuing medical education, nursing, MS pathophysiology, Free CE CME |